Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27667482 | 0.88 | NR3C1 (0.46) | NR3C1NR3C2 | |
| SCHEMBL1634784 | 0.84 | NR3C2 (0.53) | NR3C1NR3C2 | |
| SCHEMBL5203357 | 0.80 | NR3C2 (0.49) | NR3C1NR3C2 | |
| SCHEMBL6639450 | 0.79 | HTR2C (0.43) | NR3C1NR3C2 | |
| SCHEMBL4490249 | 0.76 | NR3C2 (0.51) | NR3C1NR3C2 | |
| SCHEMBL3889197 | 0.75 | NR3C2 (0.53) | NR3C1NR3C2 | |
| SCHEMBL1492607 | 0.75 | NR3C2 (0.53) | NR3C1NR3C2 | |
| SCHEMBL13823431 | 0.75 | NR3C2 (0.50) | NR3C1NR3C2 | |
| SCHEMBL10313421 | 0.75 | NR3C2 (0.50) | NR3C1NR3C2 | |
| Hydrochloric Acid SCHEMBL21632249 | 0.75 | PTGFR (0.46) | NR3C1NR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467982-B8 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND USES THEREOF | BOEHRINGER INGELHEIM PHARMA (US) | 2007-04-11 | — | — | EP | disclosed |
| EP-1467982-A1 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND USES THEREOF | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003059899-A1 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL FORMULATIONS CONTAINING THEM AND USES THEREOF | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2003-07-24 | — | — | WO | disclosed |